|
⚲
|
| Keyboard |
| Niagen Bioscience Inc
✚
|
|
|---|---|
| CIK # | 0001386570 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001386570] | |
| 10-Q | [0001386570] | |
| 3 | [0001386570] | |
| 4 | [0001386570] | |
| 5 | [0001386570] | |
| 8-K | [0001386570] | |
| D | [0001386570] | |
| SC 13D | [0001386570] | |
| SC 13G | [0001386570] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Niagen Bioscience Inc | |
| Lopez Carlos Luis | |
| Fried Robert N | |
| Pamir Ozan | |
| Cohen Ann | |
| Ng Wang Yu Gary | |
| Jaksch Frank L Jr | |
| Patrick Kristin | |
| Rubin Steven D | |
| Shahbazi Hamed | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Niagen Bioscience Inc NAGE
Employee Stock Options (right to buy) · derivative
|
2026-02-19 | Grant | 503,937 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Employee Stock Options (right to buy) · derivative
|
2026-02-19 | Grant | 41,420 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Employee Stock Options (right to buy) · derivative
|
2026-02-19 | Grant | 62,131 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Common Stock
|
2025-11-14 | Buy | 4,464.96 | $6.81 | 30,406 |
|
Niagen Bioscience Inc NAGE
Common Stock
|
2025-11-14 | Buy | 2,220.44 | $6.85 | 15,210 |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Stock Option (right to buy) · derivative
|
2025-06-24 | Grant | 20,000 | $0.00 | |
|
Niagen Bioscience Inc NAGE
Common Stock
|
2025-04-09 | Option exercise | 66,667 | $3.30 | 220,001 |
|
Niagen Bioscience Inc NAGE
Stock Options (right to buy) · derivative
|
2025-04-09 | Option exercise | 66,667 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Common Stock
|
2025-03-07 | Buy | 273 | $7.86 | 2,146 |
|
Niagen Bioscience Inc CDXC
Performance Stock Unit · derivative
|
2025-02-25 | Grant | 1,518,600 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Employee Stock Options (right to buy) · derivative
|
2025-02-12 | Grant | 19,691 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Employee Stock Options (right to buy) · derivative
|
2025-02-12 | Grant | 17,230 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Employee Stock Options (right to buy) · derivative
|
2025-02-12 | Grant | 492,278 | $0.00 | |
|
Niagen Bioscience Inc CDXC
Common Stock
|
2024-12-13 | Option exercise | 50,001 | $3.66 | 183,004 |
| showing 20 of 200 most recent transactions | |||||